These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

402 related articles for article (PubMed ID: 6939887)

  • 1. Autoantibody formation in D-penicillamine-treated rheumatoid arthritis.
    Camus JP; Homberg JC; Crouzet J; Mery C; Delrieu F; Massias P; Abuaf N
    J Rheumatol Suppl; 1981; 7():80-3. PubMed ID: 6939887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pemphigus induced by D-penicillamine in rheumatoid arthritis. Study of 5 cases and systematic study of anti-intercellular substance antibodies of the skin in the course of treatment].
    Benveniste M; Crouzet J; Homberg JC; Lessana M; Camus JP; Hewitt J
    Nouv Presse Med; 1975 Dec; 4(44):3125-8. PubMed ID: 1220709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequent induction of insulin autoantibodies by D-penicillamine in patients with rheumatoid arthritis.
    Vardi P; Brik R; Barzilai D; Lorber M; Scharf Y
    J Rheumatol; 1992 Oct; 19(10):1527-30. PubMed ID: 1464863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical and prognostic significance of antinuclear factors during D-penicillamine treatment (author's transl)].
    Helmke K; Velcovsky HG; Federlin K
    Dtsch Med Wochenschr; 1975 Oct; 100(43):2198-203. PubMed ID: 1080704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Autoimmune phenomena in D-penicillamine therapy].
    Kolarz G; Ludwig H; Sabeti M; Scherak O
    Acta Med Austriaca; 1975; 2(4):130-3. PubMed ID: 1083615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Penicillamine induced polymyositis and dermatomyositis.
    Carroll GJ; Will RK; Peter JB; Garlepp MJ; Dawkins RL
    J Rheumatol; 1987 Oct; 14(5):995-1001. PubMed ID: 3501473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoantibodies in D-penicillamine treated rheumatoid arthritis.
    Camus JP; Crouzet J; Bach JF; Homberg JC
    Agents Actions; 1976 Feb; 6(1-3):351-4. PubMed ID: 1085099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toxicity of longterm low dose D-penicillamine therapy in rheumatoid arthritis. Cooperative Systematic Studies of Rheumatic Disease Group.
    J Rheumatol; 1987 Feb; 14(1):67-73. PubMed ID: 2952797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [D-penicillamine induced myasthenic syndromes in rheumatoid arthritis. Two cases (author's transl)].
    Rodat O; Hamelin JP; Rossard A; Cottin S; Cler JM; Rodat G; Lemouroux P
    Nouv Presse Med; 1981 May; 10(20):1645-8. PubMed ID: 7255126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [D-penicillamine-induced myasthenia gravis].
    Frey RA; Keller F; Michel BA
    Schweiz Med Wochenschr; 1994 May; 124(20):852-6. PubMed ID: 8209208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cutaneous side effects induced by D-penicillamine in the treatment of rheumatoid arthritis].
    Broggini M; Baratelli E; Cappelli A; Crespi E; Filardi PG; Volontè S
    Minerva Med; 1990 Mar; 81(3):197-201. PubMed ID: 2138721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Myasthenia during treatment of rheumatoid polyarthritis with D-penicillamine].
    Carter H; Job-Deslandre C; Delrieu F; Menkes CJ
    Therapie; 1984; 39(6):689-95. PubMed ID: 6531741
    [No Abstract]   [Full Text] [Related]  

  • 13. [Are antinuclear factors a contraindication for penicillamine treatment in patients with rheumatoid arthritis? (author's transl)].
    Scherak O; Hiesberger H; Kolarz G
    Wien Klin Wochenschr; 1978 Feb; 90(3):95-6. PubMed ID: 304637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Penicillamine-induced pemphigus].
    Kind P; Goerz G; Gleichmann E; Plewig G
    Hautarzt; 1987 Sep; 38(9):548-52. PubMed ID: 3319968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Myasthenia induced by D-penicillamine during the treatment of rheumatoid polyarthritis].
    Carter H; Job-Deslandre C; Delrieu F; Kahan A; Menkès CJ
    Rev Rhum Mal Osteoartic; 1986 May; 53(5):341-4. PubMed ID: 3738397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Levamisole in rheumatoid arthritis: a comparison with D-penicillamine.
    Mowat AG; Mowat AM
    J Rheumatol; 1981; 8(4):575-80. PubMed ID: 7299760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myasthenia gravis as a complication of D-penicillamine therapy in rheumatoid arthritis.
    Wysocka K; Fabian F; Listewnik M
    Z Rheumatol; 1981; 40(3):135-7. PubMed ID: 7282112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Lupus biology: incidence and development in 84 rheumatoid polyarthritis patients treated with D-penicillamine].
    Clerc D; Sallière D; Segond P; Bisson M; Massias P
    Ann Med Interne (Paris); 1984; 135(6):420-6. PubMed ID: 6334465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Levamisole - a possible alternative to gold and penicillamine in the longterm treatment of rheumatoid arthritis?
    Capell HA; Hunter JA; Rennie JA; Murdoch RM
    J Rheumatol; 1981; 8(5):730-40. PubMed ID: 7310774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Myasthenia gravis and autoimmune thyroiditis during the treatment of rheumatoid polyarthritis withD-penicillamine. Anatomoclinical study of 1 case].
    Delrieu F; Menkes CJ; Sainte-Croix A; Babinet P; Chesneau AM; Delbarre F
    Ann Med Interne (Paris); 1976 Oct; 127(10):739-43. PubMed ID: 1008366
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 21.